These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3006084)

  • 21. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex and age-related differences in the urinary excretion of TXB2 in normal human subjects: a possible pathophysiological role of TXA2 in the aged kidney.
    Chiba S; Abe K; Kudo K; Omata K; Yasujima M; Sato K; Seino M; Imai Y; Sato M; Yoshinaga K
    Prostaglandins Leukot Med; 1984 Dec; 16(3):347-58. PubMed ID: 6597456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
    Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
    Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
    Iimura O; Shimamoto K
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between blood pressure and blood levels of angiotensin I converting enzyme inhibitor (SQ 14,225).
    Honda M; Izumi Y; Kawahara Y; Hatano M
    Jpn Circ J; 1981 Sep; 45(9):1025-9. PubMed ID: 7029028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay measurement of thromboxane B2 in human plasma and urine.
    Hornych A; Krief C; Bariety J
    Prostaglandins Leukot Med; 1982 May; 8(5):467-80. PubMed ID: 6954551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implication of endogenous prostaglandin system in the antihypertensive effect of captopril, SQ 14225, in low renin hypertension.
    Abe K; Itoh T; Imai Y; Sato M; Haruyama T; Sakurai Y; Goto T; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1980 May; 44(5):422-5. PubMed ID: 6993721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
    Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
    Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
    Rimola A; Ginés P; Arroyo V; Camps J; Pérez-Ayuso RM; Quintero E; Gaya J; Rivera F; Rodés J
    J Hepatol; 1986; 3(1):111-7. PubMed ID: 3462243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed hypotensive effect of the thromboxane A2/prostaglandin H2 receptor antagonist S-1452 in spontaneously hypertensive rats.
    Sugimoto KI; Shiga T; Fujimura A
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):594-600. PubMed ID: 10901388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
    Säynävälammi P; Pörsti I; Nurmi AK; Seppälä E; Metsä-Ketelä T; Tuomisto L; Manninen V; Vapaatalo H
    J Pharmacol Exp Ther; 1986 Apr; 237(1):246-51. PubMed ID: 3007740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.
    Tajiri Y; Umeda F; Inoguchi T; Kunisaki M; Nawata H; Ninomiya H; Asano T
    Diabetes Res; 1990 Mar; 13(3):145-50. PubMed ID: 2091882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume-induced natriuresis in healthy women: renal metabolism of prostacyclin and thromboxane, and physiological role of prostanoids.
    Agnoli GC; Borgatti R; Cacciari M; Lenzi P; Marinelli M; Stipo L
    Prostaglandins Leukot Essent Fatty Acids; 2001 Feb; 64(2):95-103. PubMed ID: 11237476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Urinary excretion of thromboxane B2 in the genetically hypertensive rat of the Lyons strain].
    Geoffroy J; Benzoni D; Vincent M; Sassard J
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):864-6. PubMed ID: 3099702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
    Baer L; Radichevich I; Williams GS
    J Cardiovasc Pharmacol; 1980; 2 Suppl 2():S206-16. PubMed ID: 6156357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of thromboxane synthesis partially protected while inhibition of angiotensin II formation did not protect rats against acute renal failure induced with glycerol.
    Papanicolaou N; Hatziantoniou C; Bariety J
    Prostaglandins Leukot Med; 1986 Jan; 21(1):29-35. PubMed ID: 3513208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of captopril on urinary excretion of prostaglandins and renin-angiotensin-aldosterone system in normal subjects.
    Zacharieva S; Koev D; Andonova K
    Acta Physiol Pharmacol Bulg; 1989; 15(4):25-30. PubMed ID: 2699540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fractional conversion of thromboxane A2 and B2 to urinary 2,3-dinor-thromboxane B2 and 11-dehydrothromboxane B2 in the cynomolgus monkey.
    Patrignani P; Morton H; Cirino M; Lord A; Charette L; Gillard J; Rokach J; Patrono C
    Biochim Biophys Acta; 1989 Jul; 992(1):71-7. PubMed ID: 2752041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excretion of primary prostanoids and their metabolites during acute volume expansion.
    Seyberth HW; Tulassay T; Kühl PG; Soeding K; Rascher W; Schweer H
    Prostaglandins; 1988 Feb; 35(2):221-32. PubMed ID: 3163156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.